Virtus Investment Advisers’s BioCryst Pharmaceuticals BCRX Stock Holding History

Virtus Investment Advisers’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$383K	Sell
2025 Q1	$354K	Buy
2023 Q1	–	Sell
2022 Q4	$274K	Sell
2022 Q3	$526K	Buy